Vanguard Group’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.5M | Buy |
|
|||||
|
2025
Q1 | $18.1M | Buy |
|
|||||
|
2024
Q4 | $12.5M | Sell |
|
|||||
|
2024
Q3 | $17.4M | Buy |
|
|||||
|
2024
Q2 | $30.2M | Buy |
|
|||||
|
2024
Q1 | $22.5M | Sell |
|
|||||
|
2023
Q4 | $14.2M | Buy |
|
|||||
|
2023
Q3 | $8.41M | Buy |
|
|||||
|
2023
Q2 | $9.44M | Sell |
|
|||||
|
2023
Q1 | $12.7M | Buy |
|
|||||
|
2022
Q4 | $19.5M | Sell |
|
|||||
|
2022
Q3 | $36.9M | Buy |
|
|||||
|
2022
Q2 | $22.2M | Sell |
|
|||||
|
2022
Q1 | $56.8M | Buy |
|
|||||
|
2021
Q4 | $87.7M | Buy |
|
|||||
|
2021
Q3 | $102M | Buy |
|
|||||
|
2021
Q2 | $145M | Buy |
|
|||||
|
2021
Q1 | $138M | Buy |
|
|||||
|
2020
Q4 | $176M | Buy |
|
|||||
|
2020
Q3 | $119M | Sell |
|
|||||
|
2020
Q2 | $118M | Buy |
|
|||||
|
2020
Q1 | $93.7M | Buy |
|
|||||
|
2019
Q4 | $185M | Buy |
|
|||||
|
2019
Q3 | $129M | Buy |
|
|||||
|
2019
Q2 | $125M | Buy |
|
|||||
|
2019
Q1 | $157M | Buy |
|
|||||
|
2018
Q4 | $164M | Buy |
|
|||||
|
2018
Q3 | $196M | Buy |
|
|||||
|
2018
Q2 | $176M | Buy |
|
|||||
|
2018
Q1 | $77.2M | Buy |
|
|||||
|
2017
Q4 | $43.8M | Buy |
|
|||||
|
2017
Q3 | $33.4M | Sell |
|
|||||
|
2017
Q2 | $29M | Buy |
|
|||||
|
2017
Q1 | $28.1M | Buy |
|
|||||
|
2016
Q4 | $17.5M | Buy |
|
|||||
|
2016
Q3 | $22.6M | Buy |
|
|||||
|
2016
Q2 | $21.9M | Buy |
|
|||||
|
2016
Q1 | $22M | Buy |
|
|||||
|
2015
Q4 | $29.4M | Buy |
|
|||||
|
2015
Q3 | $26.3M | Buy |
|
|||||
|
2015
Q2 | $27.9M | Buy |
|
|||||
|
2015
Q1 | $9.74M | Buy |
|
|||||
|
2014
Q4 | $5.79M | Buy |
|
|||||
|
2014
Q3 | $4.7M | Buy |
|
|||||
|
2014
Q2 | $6M | Buy |
|